Incidence and case fatality rates of community-acquired pneumonia and pneumococcal diseases among Korean adults: Catchment population-based analysis

被引:26
作者
Heo, Jung Yeon [1 ]
Seo, Yu Bin [2 ]
Choi, Won Suk [3 ]
Lee, Jacob [2 ]
Yoon, Jin Gu [3 ]
Lee, Saem Na [3 ]
Choi, Min Joo [3 ]
Noh, Ji Yun [3 ,4 ]
Ahn, Jin-Young [5 ,6 ]
Jeong, Hye Won [5 ,7 ]
Cheong, Hee Jin [3 ,4 ]
Kim, Woo Joo [3 ,4 ]
Lee, Hee Young [8 ]
Song, Joon Young [3 ,4 ]
机构
[1] Ajou Univ, Dept Infect Dis, Sch Med, Suwon, South Korea
[2] Hallym Univ, Coll Med, Dept Internal Med, Div Infect Dis, Chunchon, South Korea
[3] Korea Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea
[4] Korea Univ, Guro Hosp, APII, Seoul, South Korea
[5] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea
[6] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Cheongju, South Korea
[7] Chungbuk Natl Univ Hosp, Dept Internal Med, Div Infect Dis, Cheongju, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Ctr Prevent Med & Publ Hlth, Seongnam, South Korea
来源
PLOS ONE | 2018年 / 13卷 / 03期
关键词
CONJUGATE VACCINE; REQUIRING HOSPITALIZATION; COST-EFFECTIVENESS; ECONOMIC BURDEN; EPIDEMIOLOGY;
D O I
10.1371/journal.pone.0194598
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Pneumonia is a leading infectious cause of morbidity and mortality among adults. Pneumococcal pneumonia (PP) is the most common vaccine-preventable bacterial etiology of pneumonia. In this study, we estimated the incidence of community-acquired pneumonia (CAP) and pneumococcal diseases among Korean adults. Methods Clinical and microbiological databases from three hospitals were retrospectively reviewed to determine the incidence and case fatality rates of CAP and pneumococcal diseases in Korean adults aged >= 19 years from 2011 to 2014. Incidence and case fatality rates of CAP, PP and invasive pneumococcal diseases (IPD) were evaluated based on the catchment population. Catchment population was calculated using national health insurance data, estimating the proportion of patients with pneumonia that were medically attended at each hospital. Results Among 5,783 patients with medically attended CAP, 833 (14.4%) had PP. For IPD, a total of 91 culture-confirmed cases were identified. The overall incidence of CAP was 307.7 cases per 100,000 persons per year with an in-hospital mortality rate of 6.2%. The estimated annual incidence of pneumococcal pneumonia was 42.2-49.4 cases per 100,000 persons per year, increasing with age to 280 per 100,000 persons per year in older patients over 70 years. The annual incidence of IPD had a range of 4.1-6.5 cases per 100,000 persons per year. The overall case fatality rate for invasive pneumococcal diseases was 30.8% with the highest rate of 66.7% in patients over 80 years. Conclusion Over the study period, incidences of CAP, PP and IPD were consistently high, particularly in older people. These results provide baseline data to establish healthcare strategies and estimate their impact among Korean adults.
引用
收藏
页数:10
相关论文
共 38 条
  • [1] Epidemiology of community-acquired pneumonia in adults:: a population-based study
    Almirall, J
    Bolíbar, I
    Vidal, J
    Sauca, G
    Coll, P
    Niklasson, B
    Bartolomé, M
    Balanzo, X
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (04) : 757 - 763
  • [2] COMMUNITY-ACQUIRED PNEUMONIA
    BARTLETT, JG
    MUNDY, LM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1618 - 1624
  • [3] Antibiotic prescription for community-acquired pneumonia in the intensive care unit:: Impact of adherence to Infectious Diseases Society of America guidelines on survival
    Bodí, M
    Rodríguez, A
    Solé-Violán, J
    Gilavert, MC
    Garnacho, J
    Blanquer, J
    Jimenez, J
    de la Torre, MV
    Sirvent, JM
    Almirall, J
    Doblas, A
    Badía, JR
    García, F
    Mendia, A
    Jordá, R
    Bobillo, F
    Vallés, J
    Broch, MJ
    Carrasco, N
    Herranz, MA
    Rello, J
    [J]. CLINICAL INFECTIOUS DISEASES, 2005, 41 (12) : 1709 - 1716
  • [4] Overview of the disease burden of invasive pneumococcal disease in Asia
    Bravo, L. C.
    [J]. VACCINE, 2009, 27 (52) : 7282 - 7291
  • [5] CDC, 2016, ACT BACT COR SURV RE
  • [6] Disease burden of hospitalized community-acquired pneumonia in South Korea: Analysis based on age and underlying medical conditions
    Choi, Min Joo
    Song, Joon Young
    Noh, Ji Yun
    Yoon, Jin Gu
    Lee, Saem Na
    Heo, Jung Yeon
    Yoon, Jae Won
    Jo, Yu Mi
    Cheong, Hee Jin
    Kim, Woo Joo
    [J]. MEDICINE, 2017, 96 (44)
  • [7] Clinical usefulness of pneumococcal urinary antigen test, stratified by disease severity and serotypes
    Choi, Min Joo
    Song, Joon Young
    Cheong, Hee Jin
    Jeon, Ji Ho
    Kang, Seong Hui
    Jung, Eun Ju
    Noh, Ji Yun
    Kim, Woo Joo
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (09) : 672 - 679
  • [8] Chowdhary S, 2008, B WHO, V86
  • [9] A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly
    Dirmesropian, S.
    Wood, J. G.
    MacIntyre, C. R.
    Newall, A. T.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 818 - 825
  • [10] Prognosis and outcomes of patients with community-acquired pneumonia - A meta-analysis
    Fine, MJ
    Smith, MA
    Carson, CA
    Mutha, SS
    Sankey, SS
    Weissfeld, LA
    Kapoor, WN
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02): : 134 - 141